Nykode Therapeutics AS
(OSTO:NYKDo)
kr
14.25
0 (0%)
Market Cap: 2.06 Bil
Enterprise Value: 666.43 Mil
PE Ratio: 0
PB Ratio: 1.28
GF Score: 39/100 Nykode Therapeutics AS (OSTO:NYKDo) Transcripts
- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript5 days agokr14.25Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr13.05Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr16.5 (-14.46%)Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023kr28.06Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023kr25.14Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023kr26.5 (-0.08%)Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022kr27.32Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
- 1